EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access

A remote intervention to improve medication nonadherence guided by a marker of risk derived from the electronic health records of adolescent transplant recipients

Eyal Shemesh, Ravinder Anand, Rachel A Annunziato, Emily M Fredericks, Jennifer Garcia, Nitika Arora Gupta, Lawrence C Kleinman, Alyssa Kriegermeier, Krupa R Mysore, Vicky L Ng, Steven J Lobritto, Shreena Patel und 11 weitere

American Journal of Transplantation · 2026-09 · 26 (9) · 2099-2110

DOI: 10.1016/j.ajt.2026.04.030 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift American Journal of Transplantation, 2026-09. Verfasst von Eyal Shemesh und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Kravis Children's Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: eyal.s…. Hauptthemen laut MEDLINE: Liver Transplantation, Electronic Health Records, Medication Adherence, Graft Rejection. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Improving Medication Adherence in Adolescents who had a Liver Transplant (iMALT), a prospective, block-randomized, single-blind, controlled multisite study in 13 pediatric transplant centers, used the medication level variability index (MLVI) to identify non-adherent adolescents. It compared a two-year remote behavioral telemetric intervention (TI) that focused on adherence and addressed barriers, to standard of care (SOC). The primary endpoint was the composite incidence of centrally-determined (3 masked pathologists) rejection, death, re-transplantation, or consent withdrawal. In 148 participants (TI n=72, SOC n=76), mean age 15.5 years, there were twice as many primary events in SOC (12; 15.8%), as compared to TI (6; 8.3%) (RR 0·57, 95% CI 0.24–1.35, p=0.20). All secondary outcomes improved in TI vs. SOC. The study was underpowered, because iMALT sites used MLVI in clinical care, significantly reducing overall rejections as compared with the previous MALT cohort, where MLVI wasn’t used (rejection observed in 12 / 76 patients in iMALT SOC vs 13 / 25 patients in MALT; p< 0.0001). The effect on the primary outcome, therefore, was not statistically significant; thus, the intervention is not evidence-based. MLVI, an electronic health record-derived behavioral marker, can be used to target interventions to patients with clinically significant nonadherence. ClinicalTrials.Gov, NCT03691220

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationElectronic Health RecordsMedication AdherenceGraft RejectionTransplant RecipientsBiomarkersHumansAdolescentFemaleProspective StudiesMaleSingle-Blind MethodFollow-Up StudiesRisk FactorsPrognosisAdherence InterventionsImmunosuppressive AgentsGraft Survival

Stichwörter der Autor:innen

adherencebehavioral interventioncomplianceliver transplant

Substanzen

Immunosuppressive AgentsBiomarkers

Autor:innen und Institutionen

  • Department of Pediatrics and Kravis Children's Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: eyal.shemesh@mssm.edu.
  • The Emmes Company LLC, Rockville, Maryland, USA.
  • Department of Pediatrics and Kravis Children's Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Department of Pediatrics and University of Michigan Transplant Center, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Pediatric transplant Service, Miami Transplant Institute, Miami, Florida, USA.
  • Division of Pediatric Gastroenterology, Hepatology and Nutrition, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, USA.

Förderung

  • NIMH NIH HHS
  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Shemesh, E., Anand, R., Annunziato, R. A., Fredericks, E. M., Garcia, J., Gupta, N. A., Kleinman, L. C., Kriegermeier, A., Mysore, K. R., Ng, V. L., Lobritto, S. J., Patel, S., Perito, E. R., Rand, E. B., Romero, R., Venick, R. S., Duncan-Park, S., Mitchell, J., Anderson, S. G., …, & Shneider, B. L. (2026). A remote intervention to improve medication nonadherence guided by a marker of risk derived from the electronic health records of adolescent transplant recipients. American Journal of Transplantation, 26(9), 2099-2110. https://doi.org/10.1016/j.ajt.2026.04.030

Vancouver

Shemesh E, Anand R, Annunziato RA, Fredericks EM, Garcia J, Gupta NA, et al. A remote intervention to improve medication nonadherence guided by a marker of risk derived from the electronic health records of adolescent transplant recipients. American Journal of Transplantation. 2026;26(9):2099-2110. doi:10.1016/j.ajt.2026.04.030

BibTeX
@article{Shemesh2026,
  author = {Shemesh, Eyal and Anand, Ravinder and Annunziato, Rachel A and Fredericks, Emily M and Garcia, Jennifer and Gupta, Nitika Arora and Kleinman, Lawrence C and Kriegermeier, Alyssa and Mysore, Krupa R and Ng, Vicky L and Lobritto, Steven J and Patel, Shreena and Perito, Emily Rothbaum and Rand, Elizabeth B and Romero, Rene and Venick, Robert S and Duncan-Park, Sarah and Mitchell, Jeffrey and Anderson, Sarah G and Stuber, Margaret L and Reyes-Múgica, Miguel and Mazariegos, George V and Shneider, Benjamin L},
  title = {A remote intervention to improve medication nonadherence guided by a marker of risk derived from the electronic health records of adolescent transplant recipients},
  journal = {American Journal of Transplantation},
  year = {2026},
  volume = {26},
  number = {9},
  pages = {2099--2110},
  doi = {10.1016/j.ajt.2026.04.030}
}
Kostenlos starten →